NeoPharm CO., LTD. (KOSDAQ:092730)

South Korea · Delayed Price · Currency is KRW

18,900

-240 (-1.25%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Personal Products	119.01B	97.10B	85.03B	87.93B	81.63B
Personal Products Growth	22.56%	14.20%	-3.30%	7.72%	-1.94%
Total	119.01B	97.10B	85.03B	87.93B	81.63B
Total Growth	22.56%	14.20%	-3.30%	7.72%	-1.94%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	101.93B	83.00B	74.74B	79.14B	75.83B
South Korea Growth	22.81%	11.04%	-5.55%	4.36%	-
Europe	7.34B	4.85B	-	-	-
Europe Growth	51.32%	-	-	-	-
Asia	8.34B	8.77B	-	-	-
Asia Growth	-4.92%	-	-	-	-
North America	1.40B	482.84M	-	-	-
North America Growth	189.91%	-	-	-	-
Export	-	-	10.29B	8.79B	5.80B
Export Growth	-	-	17.01%	51.73%	-
Total	119.01B	97.10B	85.03B	87.93B	81.63B
Total Growth	22.56%	14.20%	-3.30%	7.72%	-

Source: S&P Global Market Intelligence.